Fortis Healthcare Limited
FORTIS
Rang in Aktien
#3023
Established in 1996 and headquartered in Gurugram, India, Fortis Healthcare... Established in 1996 and headquartered in Gurugram, India, Fortis Healthcare Limited operates as an integrated provider of healthcare services. The company extends its offerings, which encompass secondary, tertiary, and quaternary medical care, across India, the United Arab Emirates, Sri Lanka, and other international markets. Its diverse healthcare infrastructure includes a network of hospitals, diagnostic facilities, and specialized day-care centers. Fortis delivers expertise across a broad spectrum of medical disciplines, including cardiology, cosmetic and dental sciences, dermatology, endocrinology, emergency medicine, ENT, fetal medicine, gastroenterology and hepatology, general surgery, haematology, infertility treatment, internal medicine, mental and behavioral health, nephrology, neurosurgery, neurointervention, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy, plastic surgery, pulmonology, radiology, rheumatology, thoracic surgery, transplant medicine, urology, and numerous other supporting specialties. By March 31, 2022, the company managed 26 hospitals, housing approximately 4,300 operational beds, in addition to around 426 diagnostic centers and laboratories, complemented by 2,550 collection centers.
Aktienkurs
$8.02
Marktkapitalisierung
$6.06B
Veränderung (1 Tag)
-1.48%
Veränderung (1 Jahr)
-35.69%
Land
IN
Handel Fortis Healthcare Limited (FORTIS)
Kategorie
Healthcare
P/B-Verhältnis für Fortis Healthcare Limited (FORTIS)
P/B-Verhältnis zum October 2026 TTM: 5.61
Laut den neuesten Finanzberichten und dem Aktienkurs von Fortis Healthcare Limited beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 5.61. Am Ende des Jahres 2024 lag das P/B-Verhältnis bei 4.23.
P/B-Verlauf für Fortis Healthcare Limited von 2002 bis 2026
P/B-Verhältnis zum Jahresende
| Jahr | P/B-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | 5.61 | -3.76% |
| 2025 | 5.83 | 37.90% |
| 2024 | 4.23 | 55.98% |
| 2023 | 2.71 | -23.65% |
| 2022 | 3.55 | 44.44% |
| 2021 | 2.46 | 71.83% |
| 2020 | 1.43 | 7.28% |
| 2019 | 1.33 | -34.41% |
| 2018 | 2.03 | -10.20% |
| 2017 | 2.26 | -6.57% |
| 2016 | 2.42 | 7.77% |
| 2015 | 2.25 | 76.86% |
| 2014 | 1.27 | -12.70% |
| 2013 | 1.46 | -26.61% |
| 2012 | 1.98 | -31.40% |
| 2011 | 2.89 | -49.39% |
| 2010 | 5.71 | 73.01% |
| 2009 | 3.30 | -14.32% |
| 2008 | 3.85 | -65.22% |
| 2007 | 11.08 | -46.53% |
| 2006 | 20.72 | -92.72% |
| 2005 | 284.65 | -3.64% |
| 2004 | 295.40 | 31.31% |
| 2003 | 224.97 | 57.91% |
| 2002 | 142.46 | 0.00% |
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/B-Verhältnis | P/B-Verhältnis-Differenz | Land |
|---|---|---|---|
| -15.9433 | -384.14% |
US
|
|
| - | - |
DE
|
|
| 4.8701 | -13.20% |
US
|
|
| 9.3882 | 67.32% |
SA
|
|
| 4.6058 | -17.91% |
BR
|
